Brief: Innovative Pharmaceutical Biotech Says FY Loss Attributable HK$245.7 Mln
June 29 (Reuters) - Innovative Pharmaceutical Biotech
Ltd 0399.HK :
* FY LOSS ATTRIBUTABLE HK$245.7 MILLION VERSUS PROFIT OF
HK$45.8
MILLION
* FY REVENUE HK$8.1 MILLION VERSUS HK$11.1 MILLION
Further company coverage: 0399.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Starcoin
See all newsBrief: Starcoin Group Says Trading In Shares Of Co Will Suspend From 6 May
Brief: Starcoin Enters Non-Binding Memorandum Of Understanding With Marvel Nice
Brief: Starcoin Group Enters MoU For Strategic Cooperation With Huamei Haibo Biotechnology (Chongqing)
Brief: Starcoin Group Says Unit, Others Enters Deal For Brazilian Gold Mine RWA Tokenization
Brief: Starcoin Group, Newbridge And Conflux Foundation Entered MoU